| Antigen availability shapes T cell differentiation and function during tuberculosis AO Moguche, M Musvosvi, A Penn-Nicholson, CR Plumlee, H Mearns, ... Cell host & microbe 21 (6), 695-706. e5, 2017 | 173 | 2017 |
| Safety and immunogenicity of the novel tuberculosis vaccine ID93+ GLA-SE in BCG-vaccinated healthy adults in South Africa: a randomised, double-blind, placebo-controlled phase … A Penn-Nicholson, M Tameris, E Smit, TA Day, M Musvosvi, ... The Lancet Respiratory Medicine 6 (4), 287-298, 2018 | 149 | 2018 |
| Live-attenuated Mycobacterium tuberculosis vaccine MTBVAC versus BCG in adults and neonates: a randomised controlled, double-blind dose-escalation trial M Tameris, H Mearns, A Penn-Nicholson, Y Gregg, N Bilek, S Mabwe, ... The lancet Respiratory medicine 7 (9), 757-770, 2019 | 123 | 2019 |
| Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial TJ Scriba, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, SK Mbandi, ... The Lancet Infectious Diseases 21 (3), 354-365, 2021 | 109 | 2021 |
| MR1-independent activation of human mucosal-associated invariant T cells by mycobacteria S Suliman, M Murphy, M Musvosvi, A Gela, EW Meermeier, H Geldenhuys, ... The Journal of Immunology 203 (11), 2917-2927, 2019 | 63 | 2019 |
| T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation M Musvosvi, D Duffy, E Filander, H Africa, S Mabwe, L Jaxa, N Bilek, ... European Respiratory Journal 51 (3), 2018 | 57 | 2018 |
| Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells Are Induced by Human Mycobacterium tuberculosis Infection CAM Mpande, OB Dintwe, M Musvosvi, S Mabwe, N Bilek, M Hatherill, ... Frontiers in immunology 9, 324, 2018 | 51 | 2018 |
| Differential Recognition of Mycobacterium tuberculosis–Specific Epitopes as a Function of Tuberculosis Disease History TJ Scriba, C Carpenter, SC Pro, J Sidney, M Musvosvi, V Rozot, ... American journal of respiratory and critical care medicine 196 (6), 772-781, 2017 | 50 | 2017 |
| Group A streptococcal emm type prevalence among symptomatic children in Cape Town and potential vaccine coverage ME Engel, B Muhamed, AC Whitelaw, M Musvosvi, BM Mayosi, JB Dale The Pediatric infectious disease journal 33 (2), 208-210, 2014 | 47 | 2014 |
| H1: IC31 vaccination is safe and induces long-lived TNF-α+ IL-2+ CD4 T cell responses in M. tuberculosis infected and uninfected adolescents: A randomized trial H Mearns, HD Geldenhuys, BM Kagina, M Musvosvi, F Little, F Ratangee, ... Vaccine 35 (1), 132-141, 2017 | 46 | 2017 |
| Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study SC Mendelsohn, A Fiore-Gartland, A Penn-Nicholson, H Mulenga, ... The Lancet Global Health 9 (6), e841-e853, 2021 | 44 | 2021 |
| A functional toll-interacting protein variant is associated with Bacillus calmette-guérin–specific immune responses and tuberculosis JA Shah, M Musvosvi, M Shey, DJ Horne, RD Wells, GJ Peterson, JS Cox, ... American journal of respiratory and critical care medicine 196 (4), 502-511, 2017 | 42 | 2017 |
| T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection M Musvosvi, H Huang, C Wang, Q Xia, V Rozot, A Krishnan, P Acs, ... Nature Medicine 29 (1), 258-269, 2023 | 35 | 2023 |
| Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection CAM Mpande, M Musvosvi, V Rozot, B Mosito, TD Reid, C Schreuder, ... American Journal of Respiratory and Critical Care Medicine 203 (12), 1556-1565, 2021 | 34 | 2021 |
| Immune profiling of Mycobacterium tuberculosis-specific T cells in recent and remote infection CAM Mpande, V Rozot, B Mosito, M Musvosvi, OB Dintwe, N Bilek, ... EBioMedicine 64, 2021 | 26 | 2021 |
| Immune Profiling Enables Stratification of Patients With Active Tuberculosis Disease or Mycobacterium tuberculosis Infection D Duffy, E Nemes, A Llibre, V Rouilly, M Musvosvi, N Smith, E Filander, ... Clinical Infectious Diseases 73 (9), e3398-e3408, 2021 | 23 | 2021 |
| Longitudinal dynamics of a blood transcriptomic signature of tuberculosis H Mulenga, M Musvosvi, SC Mendelsohn, A Penn-Nicholson, ... American journal of respiratory and critical care medicine 204 (12), 1463-1472, 2021 | 22 | 2021 |
| The SIGLEC14 null allele is associated with Mycobacterium tuberculosis-and BCG-induced clinical and immunologic outcomes AD Graustein, DJ Horne, JJ Fong, F Schwarz, HC Mefford, GJ Peterson, ... Tuberculosis 104, 38-45, 2017 | 21 | 2017 |
| Multidimensional analyses reveal modulation of adaptive and innate immune subsets by tuberculosis vaccines V Rozot, E Nemes, H Geldenhuys, M Musvosvi, A Toefy, F Rantangee, ... Communications biology 3 (1), 563, 2020 | 19 | 2020 |
| Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR SC Mendelsohn, SK Mbandi, A Fiore-Gartland, A Penn-Nicholson, ... Communications medicine 2 (1), 26, 2022 | 18 | 2022 |
